4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000950170-24-110484
President and CEO bought 21,400 shares at $23.33 ($499,262)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mahoney Stephen F. President and CEO | 2024-09-27 | Purchase | +21,400 | $23.33 | $499,262 | 21,400 | D |
| Open-market purchases · 21,400 sh · avg $23.33 · $499,262 | |||||||
Loading xslF345X05/ownership.xml…